Status:
COMPLETED
Predicting Endometrial Receptivity for Optimal Reproductive Management
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Infertility, Female
Endometriosis
Eligibility:
FEMALE
18-42 years
Brief Summary
The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detec...
Detailed Description
The investigators will recruit 100 women who are undergoing IVF with egg retrieval and delayed embryo transfer to consent to endometrial biopsy 1 week after egg retrieval. Currently most women in the ...
Eligibility Criteria
Inclusion
- Age - 18 to 42
- AMH ≥ 1
- Planning to undergo IVF with delayed embryo transfer
- Must have blastocyst(s) by day 6 that were biopsied for PGT-A
- BMI 18-35
Exclusion
- Uterine fibroids \> 4 cm in size
- Polycystic ovary syndrome (PCOS) according with the Rotterdam criteria.
- Ovarian failure and subjects receiving donor oocytes/embryos
- Anti-cardiolipid and/or lupus anti-coagulant abnormalities by history
- Diabetes mellitus (Type I or Type II)
- Untreated hypothyroidism
- Hyperprolactinemia
- Uncorrected uterine anomaly
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04107129
Start Date
July 1 2020
End Date
July 30 2024
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Fertility and Reproductive Health
Sunnyvale, California, United States, 94087